COVID-19 is the disease caused by a coronavirus called SARS-CoV-2, which was discovered in 2019. In the months since the disease was first detected, researchers from the IU Precision Health Initiative jumped into action to learn more about the virus and help answer some of the many unanswered questions about COVID-19.
The IU Precision Health Initiative's COVID-19 team plans to work with the genomic medicine pillar on whole exome sequencing and RNA transcriptomics of certain COVID-19 research samples. The data and informatics pillar will store data from their research utilizing the precision health cloud. Indiana Clinical and Translational Sciences Institute cores, such as the access technology core, will also be used to help generate data on cytokine/chemokines.
The goal of this special disease state is the same as the overall goals of the IU Precision Health Initiative — to find treatments, cures and even preventions for COVID-19.